Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease.
Saved in:
| Title: | Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease. |
|---|---|
| Authors: | Sim WC; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee W; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Sim H; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee KY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Jung SH; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Choi YJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Kim HY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Kang KW; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee JY; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Choi YJ; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Kim SK; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Jun DW; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea., Kim W; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Lee BH; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. Electronic address: lee@snu.ac.kr. |
| Source: | Metabolism: clinical and experimental [Metabolism] 2020 Jan; Vol. 102, pp. 154000. Date of Electronic Publication: 2019 Oct 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0375267 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8600 (Electronic) Linking ISSN: 00260495 NLM ISO Abbreviation: Metabolism Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 31678070 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sim+WC%22">Sim WC</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+W%22">Lee W</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Sim+H%22">Sim H</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+KY%22">Lee KY</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jung+SH%22">Jung SH</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+YJ%22">Choi YJ</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+HY%22">Kim HY</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kang+KW%22">Kang KW</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JY%22">Lee JY</searchLink>; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Choi+YJ%22">Choi YJ</searchLink>; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+SK%22">Kim SK</searchLink>; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jun+DW%22">Jun DW</searchLink>; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+W%22">Kim W</searchLink>; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+BH%22">Lee BH</searchLink>; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. Electronic address: lee@snu.ac.kr. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220375267%22">Metabolism: clinical and experimental</searchLink> [Metabolism] 2020 Jan; Vol. 102, pp. 154000. <i>Date of Electronic Publication: </i>2019 Oct 31. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Inc%22">Elsevier Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0375267 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-8600 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200260495%22">00260495 </searchLink><i>NLM ISO Abbreviation: </i>Metabolism <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31678070 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.metabol.2019.154000 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 154000 Titles: – TitleFull: Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sim WC – PersonEntity: Name: NameFull: Lee W – PersonEntity: Name: NameFull: Sim H – PersonEntity: Name: NameFull: Lee KY – PersonEntity: Name: NameFull: Jung SH – PersonEntity: Name: NameFull: Choi YJ – PersonEntity: Name: NameFull: Kim HY – PersonEntity: Name: NameFull: Kang KW – PersonEntity: Name: NameFull: Lee JY – PersonEntity: Name: NameFull: Choi YJ – PersonEntity: Name: NameFull: Kim SK – PersonEntity: Name: NameFull: Jun DW – PersonEntity: Name: NameFull: Kim W – PersonEntity: Name: NameFull: Lee BH IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2020 Jan Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1532-8600 Numbering: – Type: volume Value: 102 Titles: – TitleFull: Metabolism: clinical and experimental Type: main |
| ResultId | 1 |